Indoles and 1-(3-(benzyloxy)benzyl)piperazines: reversible and selective monoamine oxidase B inhibitors identified by screening an in-house compound library

2021 ◽  
pp. 105581
Author(s):  
Damijan Knez ◽  
Martina Hrast ◽  
Rok Frlan ◽  
Anja Pišlar ◽  
Simon Žakelj ◽  
...  
2016 ◽  
Vol 22 (21) ◽  
pp. 3082-3096 ◽  
Author(s):  
Aliuska Morales Helguera ◽  
Yunierkis Perez-Castillo ◽  
M. Natália D.S. Cordeiro ◽  
Eduardo Tejera ◽  
César Paz-y-Miño ◽  
...  

Heliyon ◽  
2021 ◽  
Vol 7 (4) ◽  
pp. e06684
Author(s):  
Hunday Govindasamy ◽  
Sivanandam Magudeeswaran ◽  
Saravanan Kandasamy ◽  
Kumaradhas Poomani

Molecules ◽  
2021 ◽  
Vol 26 (14) ◽  
pp. 4118
Author(s):  
Tjaša Mazej ◽  
Damijan Knez ◽  
Anže Meden ◽  
Stanislav Gobec ◽  
Matej Sova

The multi-target-directed ligands (MTDLs) strategy is encouraged for the development of novel modulators targeting multiple pathways in the neurodegenerative cascade typical for Alzheimer’s disease (AD). Based on the structure of an in-house irreversible monoamine oxidase B (MAO-B) inhibitor, we aimed to introduce a carbamate moiety on the aromatic ring to impart cholinesterase (ChE) inhibition, and to furnish multifunctional ligands targeting two enzymes that are intricately involved in AD pathobiology. In this study, we synthesized three dual hMAO-B/hBChE inhibitors 13–15, with compound 15 exhibiting balanced, low micromolar inhibition of hMAO-B (IC50 of 4.3 µM) and hBChE (IC50 of 8.5 µM). The docking studies and time-dependent inhibition of hBChE confirmed the initial expectation that the introduced carbamate moiety is responsible for covalent inhibition. Therefore, dual-acting compound 15 represents an excellent starting point for further optimization of balanced MTDLs.


2021 ◽  
Vol 36 (1) ◽  
pp. 188-197
Author(s):  
Rani Sasidharan ◽  
Bo Hyun Eom ◽  
Jeong Hyun Heo ◽  
Jong Eun Park ◽  
Mohamed A. Abdelgawad ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document